Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03967561
Other study ID # 2.855.513
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 10, 2019
Est. completion date November 15, 2019

Study information

Verified date June 2019
Source Federal University of Rio Grande do Sul
Contact Luiz FM Kruel, phd
Phone +555133085820
Email kruel@esef.ufrgs.br
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized clinical trial with the aim to evaluate the effects of two water-based aerobic training programs (walking or running in shallow pool) on type 2 diabetes control. The sample will be composed by 50 individuals with type 2 diabetes, of both sexes, aged between 40 and 70 years, who will be randomized into water-based progressive aerobic training (PAT, n=25) and water-based non-progressive aerobic training (NPAT, n=25). Both trainings will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each). Biochemical, cardiorespiratory fitness, maximum strength, body composition and functional mobility variables, as also quality of life, sleep quality and depressive symptoms will be analyzed before and after the 12 weeks of training.


Description:

Water-based aerobic training can provide benefits with important clinical implications for type 2 diabetes (T2D) patients, as the aquatic environment provides some interesting advantages to this population. The lower impact on joints and consequent reduced chance of injury allows considering the aquatic environment favorable to the principle of continuity with progression of physiological stimuli and metabolic benefits.

In T2D individuals, studies have been analyzing the effects of water-based aerobic training in upright position, which have been promoting several results in metabolic parameters of T2D individuals, including benefits in glucose and lipids levels and in cardiorespiratory fitness.

The literature shows distinct exercise effects on glucose control of T2D patients, resulting from different forms of training structuring, with and without progression of training variables. Well-conducted clinical trials prescribing aerobic training according to American Diabetes Association (ADA) recommendations (i.e. structured aerobic training with weekly duration of at least 150 minutes of moderate to vigorous intensity performed in three or more sessions per week) but with minimal or without progression in training load found no HbA1c reductions, whereas some studies that did not meet the recommendations but progressed training volume and/or intensity over time found interesting HbA1c reductions. With these findings, it seems that the optimization of aerobic training benefits on glucose control may not solely depend on a fixed training dosage, but also on the progression of the volume and/or intensity of training.

Due to the associations between T2D with obesity and hypertension, conditions that create difficulties for individuals performing exercise while supporting their own body mass, the different responses arising from the studies investigating progressive and non-progressive aerobic trainings in T2D patients, and with the important facilities that the aquatic environment can promote during physical exercise performance, it becomes interesting to investigate the effects of the application of two aquatic aerobic trainings on T2D treatment, in which similar exercise programs are performed, with one of them having its training variables fixed over time (non-progressive training) and the other with progression in the variables (progressive training). To the present moment, no clinical trial has investigated the comparison between aquatic aerobic training interventions with and without progression in the training variables on glycemic control of T2D individuals, aiming at exploring the role of training progression.

For this purpose, a randomized clinical trial with the aim to evaluate the effects of two water-based aerobic training programs (walking or running in shallow pool) on T2D management will be performed. The sample will be composed by 50 individuals with T2D, of both sexes, aged between 40 and 70 years, who will be randomized into water-based progressive aeroibic training (PAT, n=25) and water-based non-progressive aerobic training (NPAT, n=25). Both trainings will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each). Biochemical, cardiorespiratory fitness, maximum strength, body composition and functional mobility variables, as also quality of life, sleep quality and depressive symptoms will be analyzed before and after the 12 weeks of training.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date November 15, 2019
Est. primary completion date October 30, 2019
Accepts healthy volunteers No
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- Individuals with type 2 diabetes, of both sexes, aged between 40 and 70 years.

- Be under medical treatment with oral hypoglycemic agents and / or insulin;

- Not be engaged in regular exercise (regular exercise was defined as performing any type of physical training for at least 20 minutes three or more days a week).

Exclusion Criteria:

- Presence of:

- uncontrolled hypertension;

- autonomic neuropathy;

- severe peripheral neuropathy;

- proliferative diabetic retinopathy;

- severe non-proliferative diabetic retinopathy;

- uncompensated heart failure;

- peripheral amputations;

- chronic kidney failure;

- body mass index (BMI)> 45.0 kg/m2;

- to have some muscle or joint impairment that prevents the performance of physical exercises safely.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Progressive water-based aerobic training
The intervention will comprise walking/running in shallow pool with progression in the training variables. The training will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each).
Non-progressive aerobic training
The intervention will comprise walking/running in shallow pool without progression in the training variables. The training will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each).

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Federal University of Rio Grande do Sul Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Outcome

Type Measure Description Time frame Safety issue
Primary Glycated Hemoglobin levels (HbA1c) Blood samples will be used to analyze glycated hemoglobin levels (%) Change from baseline levels of glycated hemoglobin to 12 weeks of intervention.
Secondary Fasting plasma glucose in mg/dL At baseline and after a 12-week period
Secondary Fasting insulin in mg/dL At baseline and after a 12-week period
Secondary Insulin-resistance index (HOMA-IR) in amount At baseline and after a 12-week period
Secondary Total cholesterol in mg/dL At baseline and after a 12-week period
Secondary High density lipoprotein in mg/dL At baseline and after a 12-week period
Secondary Low density lipoprotein in mg/dL At baseline and after a 12-week period
Secondary Triglycerides in mg/dL At baseline and after a 12-week period
Secondary Plasma renin in uIU/mL (microliter) At baseline and after a 12-week period
Secondary C-reactive protein in mg/L At baseline and after a 12-week period
Secondary Peak oxygen uptake in ml.kg.min-1 At baseline and after a 12-week period
Secondary Oxygen uptake at the second ventilatory threshold. in ml.kg.min-1 At baseline and after a 12-week period
Secondary Percentage of oxygen consumption in the second ventilatory threshold from the peak oxygen uptake in % At baseline and after a 12-week period
Secondary Systolic blood pressure. in mmHg At baseline and after a 12-week period
Secondary Diastolic blood pressure. in mmHg At baseline and after a 12-week period
Secondary Resting heart rate in beats per minute At baseline and after a 12-week period
Secondary Maximum dynamic muscle strength (1RM) in the knees extension exercise The test is characterized by greatest load that can be supported in a single execution of knees extension exercise. At baseline and after a 12-week period
Secondary Muscular resistance (maximal repetitions) in the knees extension exercise. To determine muscular resistance, it will be considered the number of repetitions performed at 60% of 1RM, following a paced pre-established execution. In the post-training evaluation, we will use the load of 60% of 1RM test performed in the pre-training. At baseline and after a 12-week period
Secondary Timed up-and-go test performed at the usual speed. In seconds At baseline and after a 12-week period
Secondary Timed up-and-go test performed at the maximal speed. In seconds At baseline and after a 12-week period
Secondary Overall quality of life and in physical, psychological, social relationships and environment domains, evaluated by instrument of World Health Organization (WHOQOL). To evaluate the quality of life we used the WHOQOL-brief instrument. This instrument is self-applicable, cross-cultural, translated and validated for Portuguese, consisting of 26 questions. Its score ranges from zero to 100 points, divided into the physical, psychological, social relationships and environment, as well as an assessment of the overall quality of life. At baseline and after a 12-week period
Secondary Depressive symptoms, evaluated by Depression Inventory Patient Health Questionnaire (PHQ-9) For evaluation of depressive symptoms was used the questionnaire PHQ-9 depression, which consists of nine items, including symptoms and attitudes whose intensity varies from zero to three, with 27 being the higher score. At baseline and after a 12-week period
Secondary Sleep quality, evaluated by Pittsburgh Sleep Scale Sleep quality was assessed by Pittsburgh scale, consisting of 19 questions on the perception of oneself and five questions relating to the perception that the roommates of these individuals have about sleep the same. These questions are grouped into seven components, with score of zero to three. At baseline and after a 12-week period
Secondary Physical activity levels, evaluated by International Physical Activity Questionnaire (IPAQ) - Long Form. The IPAQ asks about three specific types of activity undertaken in the three domains introduced above and sitting time. The specific types of activity that are assessed are walking, moderate-intensity activities and vigorous intensity activities; frequency (measured in days per week) and duration (time per day) are collected separately for each specific type of activity. At baseline and after a 12-week period
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2